MOLLY NIXON: Open Payments
NPI 1497252860 · NICEVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 9 payments from 7 companies in 2025. Trend: 2023 $984 · 2024 $229 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| McKesson Medical-Surgical, Inc. | 1 | $50 |
| Lilly USA, LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $31 |
| Lundbeck LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: JARDIANCE, Ozempic, REXULTI, Kerendia, TRELEGY ELLIPTA, LEQVIO.
Industry payments across FL — which companies pay providers there.
